Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
E. R. Israelyan
Observed names:
E. R. Israyelyan,
E.R. Israelyan,
E. R. Israelyan,
Edgar Israelyan,
Эдгар Р. Исраелян
Institutions:
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
Observed institutions:
Rostov State Medical University,
Pirogov Russian National Research Medical University,
Russian Cancer Research Center NN Blokhin,
Ministry of Health of the Russian Federation
ORCID:
0000-0002-6666-549X
Observed ORCID:
0000-0002-6666-549X
OpenAlex ID:
A5004149783
Efficacy of non‑platinum chemotherapy in platinum‑resistant ovarian cancer: a meta‑analysis
2022
·
A. A. Rumyantsev
, A. S. Tyulyandina
, et al.
·
Malignant tumours
·
2
PDF
Prediction of small-diameter arterial fibrosis in patients with hypertension and primary chronic glomerulonephritis
2020
·
E. S. Levitskaya
, M. M. Batyushin
, et al.
·
CARDIOVASCULAR THERAPY AND PREVENTION
·
2
PDF
Onset of multiple myeloma with rheumatic polymyalgia
2019
·
E. R. Israelyan
, C. S. Golovataya
, et al.
·
Medical Herald of the South of Russia
·
2
PDF
Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors study
2026
·
Michal Mego
, Edgar Israelyan
, et al.
·
British Journal of Cancer
·
1
PDF
Analysis of the Efficacy and Safety of Avelumab Maintenance Therapy in Subgroups of Patients with Metastatic Urothelial Carcinoma in Real-World Practice (RAVE-Bladder Study)
2026
·
Ya. V. Gridneva
, M. I. Volkova
, et al.
·
Malignant tumours
·
1
PDF
BRCA-associated ovarian cancer in the russian patient population. Analysis of the non-interventional study Ovatar
2024
·
T. T. Tikhomirova
, A. S. Tyulyandina
, et al.
·
Malignant tumours
·
1
PDF
Paclitaxel, ifosfamide, cisplatin (TIP) for the treatment of intermediateand poor-risk nonseminomatous germ cell tumors with an inadequate decrease in tumor markers: a phase II study
2022
·
E. R. Israelyan
, A. A. Tryakin
, et al.
·
Malignant tumours
·
1
PDF
Therapy options for metastatic triple negative breast cancer
2022
·
E. V. Glazkova
, M. A. Frolova
, et al.
·
Meditsinskiy sovet = Medical Council
·
1
PDF
Platinum-containing regimens in first-line therapy for cervical cancer: efficacy and safety analysis using a pseudorandomization method
2026
·
Alina V. Trusova
, A. A. Rumyantsev
, et al.
·
Surgery and Oncology
Comparative effectiveness of carboplatin- versus cisplatin-based first-line chemotherapy in cisplatin-eligible patients with metastatic urothelial carcinoma
2026
·
Avasherfe S. Ablyametova
, A. A. Rumyantsev
, et al.
·
Surgery and Oncology
Efficacy of pembrolizumab plus lenvatinib versus alternative drug regimens in patients with recurrent endometrial cancer after platinum based chemotherapy: a retrospective cohort study
2026
·
Angelina N. Letuchikh
, A. А. Rumyantsev
, et al.
·
Surgery and Oncology
Maintenance therapy with avelumab for metastatic urothelial cancer: data from real clinical practice
2026
·
A. S. Ablyametova
, A. A. Rumyantsev
, et al.
·
Malignant tumours
PDF
Surveillance versus retroperitoneal lymph node dissection after induction chemotherapy in patients with seminomatous testicular germ cell tumours metastatic to retroperitoneal lymph nodes: a comparative analysis
2026
·
Ekaterina M. Nikolaeva
, E. R. Israelyan
, et al.
·
Cancer Urology
PDF
dd-MVAC as neoadjuvant chemotherapy for muscle-invasive bladder cancer: a single-center study
2026
·
Tatiana E. Tikhomirova
, A. Yu. Anokhin
, et al.
·
Cancer Urology
Induction chemotherapy regimens in malignant trophoblastic tumors with high risk of resistance: retrospective study
2025
·
A. S. Tsareva
, А. А. Rumyantsev
, et al.
·
Surgery and Oncology
PDF
Aspects of hypogonadism in oncological patients receiving antitumor treatment. Literature review
2025
·
M. E. Abramov
, E. R. Israelyan
, et al.
·
Cancer Urology
PDF
TIP regimen (paclitaxel, ifosfamide, cisplatin) in nonseminomatous germ cell tumors with poor-prognosis and unfavorable decline of serum tumor markers: final results
2025
·
E. R. Israelyan
, A. A. Tryakin
, et al.
·
Malignant tumours
PDF
Treatment of a patient with disseminated testicular germ cell tumor associated with terminal chronic kidney disease requiring hemodialysis
2024
·
A. S. Ablyametova
, A. V. Zorinova
, et al.
·
Malignant tumours
PDF
Choriocarcinoma of the ovaries: the role of molecular-genetic testing in the differential diagnosis of gestational and non-gestational forms
2024
·
A. N. Letuchikh
, A. S. Ablyametova
, et al.
·
Malignant tumours
Paclitaxel, gemcitabine, oxaliplatin regimen in induction therapy of patients with relapsed and refractory germ cell tumors before high-dose chemotherapy: results of a pilot study
2022
·
E. R. Israelyan
, A. A. Rumyantsev
, et al.
·
Malignant tumours
PDF
Olaparib maintenance therapy after frontline chemotherapy in patients with BRCA-mutated ovarian cancer: real-world results in expanded access program
2022
·
A. A. Rumyantsev
, A. S. Tyulyandina
, et al.
·
Meditsinskiy sovet = Medical Council
PDF
Surrogate endpoints in platinum-resistant recurrent ovarian cancer
2022
·
A.A. Rumyantsev
, A.S. Tyulyandina
, et al.
·
Russian Medical Inquiry
PDF
Show more works
View as search
Works count:
23
Citation count:
12
H-index:
2
I10-index:
Year
Topic
Type